IBRX EBITDA Growth
Immunitybio Inc · EBITDA Growth
IBRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-275.20%period ending
IBRX TTM EBITDA YoY % (52.50% → -275.20%)
Year-over-year change
High-resolution chart · PNG
IBRX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -275.1981% | |
| -169.4473% | |
| 17.1956% | |
| 45.4696% | |
| 46.1256% | |
| 40.3359% | |
| 38.147% | |
| -35.757% | |
| -27.4273% | |
| -39.4209% | |
| -32.372% | |
| 7.2115% | |
| -4.583% | |
| 3.1172% | |
| -2.8037% | |
| -26.9486% | |
| -33.7637% | |
| -57.5616% | |
| -88.6765% | |
| -67.1089% | |
| -123.3332% | |
| -166.4152% | |
| -172.093% | |
| -175.8878% | |
| -69.7999% | |
| -5.3774% | |
| 27.9706% | |
| 39.2543% | |
| 32.3955% | |
| 18.9615% | |
| 4.3987% | |
| -5.6261% | |
| 2.508% | |
| 15.7798% | |
| 22.9% | |
| 47.5315% | |
| 45.9414% | |
| 52.5013% |